{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_004772.4:c.1245C>T",
          "cDNA Change": {
            "transcript": "NM_004772.4",
            "ref": "C",
            "alt": "T",
            "position": "1245"
          },
          "Protein Change": {
            "ref": "L",
            "alt": "P",
            "position": "415"
          },
          "Description in input context": "A previously reported pathogenic variant identified in a patient with early-onset Parkinson’s disease."
        },
        {
          "HGVS": "NM_004772.4:c.1574G>A",
          "cDNA Change": {
            "transcript": "NM_004772.4",
            "ref": "G",
            "alt": "A",
            "position": "1574"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "Q",
            "position": "525"
          },
          "Description in input context": "This variant was predicted to disrupt protein folding based on in-silico analysis."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0003394"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Patient-derived Fibroblasts",
        "Material Name": "Fibroblast cell lines from Parkinson's patients",
        "Description": "Fibroblast cells were obtained from patient samples carrying known PINK1 mutations."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004772.4:c.1245C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "Western blot analysis revealed a near absence of PINK1 protein in fibroblast cell lines carrying the NM_004772.4:c.1245C>T variant."
        },
        {
          "Variant": "NM_004772.4:c.1574G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "Western blot analysis demonstrated a significant reduction (approximately 60%) of PINK1 protein levels in fibroblast cell lines carrying the NM_004772.4:c.1574G>A variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent fibroblast cell lines were used as biological replicates for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate for each blot."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Fibroblast cell lines from healthy donors were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Cells transfected with an empty vector were included as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA followed by post-hoc Tukey's test for multiple comparisons was performed to analyze protein expression levels."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression between 50% and 150% of control samples.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression outside the range of 50% to 150% of control samples.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunofluorescence",
      "Material used": {
        "Material Source": "Brain tissue sections from Parkinson's patients",
        "Material Name": "Post-mortem brain tissue samples",
        "Description": "Brain tissue sections were obtained from a cohort of Parkinson's disease patients and age-matched controls."
      },
      "Readout type": "Qualitative/Semi-Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004772.4:c.1245C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "Immunofluorescence staining revealed a severe reduction in PINK1 protein expression in neurons from Parkinson’s disease patients carrying the NM_004772.4:c.1245C>T variant compared to control samples."
        },
        {
          "Variant": "NM_004772.4:c.1574G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "Immunofluorescence staining showed a decrease in PINK1 protein expression, though not as severe as with the complete loss-of-function variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Analysis of tissue sections from at least three different patients with each variant was performed."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "Images were captured once per tissue section."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Brain tissue from age-matched control subjects were used as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "No primary antibody control was used, relying on the specificity of established antibodies."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Qualitative assessment based on visual comparison of staining intensity."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Strong and diffuse staining for PINK1 across neuronal cell bodies.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Reduced or absent staining for PINK1.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}